カテゴリー： 世界, 医療/バイオ, QYResearch

神経遺伝検査の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Neurogenetic Testing Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09260）・商品コード：QY22JLX09260
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、神経遺伝検査のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に神経遺伝検査の世界市場のxxx％を占める「MRI」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
神経遺伝検査の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの神経遺伝検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

神経遺伝検査のグローバル主要企業には、Labcorp、Pacific Biosciences of California、Victorian Clinical Genetics Services、MedGenome Labs、Blueprint Genetics、GeneDx、Mayo Clinic、Neurogeneなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

神経遺伝検査市場は、種類と用途によって区分されます。世界の神経遺伝検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
MRI、次世代配列、多重ライゲーション依存プローブ増幅（MLPA）、フラグメント分析PCR

【用途別セグメント】
病院、専門クリニック、研究機関、診断研究所

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 神経遺伝検査製品概要
- 種類別市場（MRI、次世代配列、多重ライゲーション依存プローブ増幅（MLPA）、フラグメント分析PCR）
- 用途別市場（病院、専門クリニック、研究機関、診断研究所）
- 調査の目的
・エグゼクティブサマリー
- 世界の神経遺伝検査販売量予測2017-2028
- 世界の神経遺伝検査売上予測2017-2028
- 神経遺伝検査の地域別販売量
- 神経遺伝検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別神経遺伝検査販売量
- 主要メーカー別神経遺伝検査売上
- 主要メーカー別神経遺伝検査価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（MRI、次世代配列、多重ライゲーション依存プローブ増幅（MLPA）、フラグメント分析PCR）
- 神経遺伝検査の種類別販売量
- 神経遺伝検査の種類別売上
- 神経遺伝検査の種類別価格
・用途別市場規模（病院、専門クリニック、研究機関、診断研究所）
- 神経遺伝検査の用途別販売量
- 神経遺伝検査の用途別売上
- 神経遺伝検査の用途別価格
・北米市場
- 北米の神経遺伝検査市場規模（種類別、用途別）
- 主要国別の神経遺伝検査市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの神経遺伝検査市場規模（種類別、用途別）
- 主要国別の神経遺伝検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の神経遺伝検査市場規模（種類別、用途別）
- 主要国別の神経遺伝検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の神経遺伝検査市場規模（種類別、用途別）
- 主要国別の神経遺伝検査市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの神経遺伝検査市場規模（種類別、用途別）
- 主要国別の神経遺伝検査市場規模（トルコ、サウジアラビア）
・企業情報
Labcorp、Pacific Biosciences of California、Victorian Clinical Genetics Services、MedGenome Labs、Blueprint Genetics、GeneDx、Mayo Clinic、Neurogene
・産業チェーン及び販売チャネル分析
- 神経遺伝検査の産業チェーン分析
- 神経遺伝検査の原材料
- 神経遺伝検査の生産プロセス
- 神経遺伝検査の販売及びマーケティング
- 神経遺伝検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 神経遺伝検査の産業動向
- 神経遺伝検査のマーケットドライバー
- 神経遺伝検査の課題
- 神経遺伝検査の阻害要因
・主な調査結果

Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson’s disease, epilepsy, and more.
Market Analysis and Insights: Global Neurogenetic Testing Market
The global Neurogenetic Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, MRI accounting for % of the Neurogenetic Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Neurogenetic Testing market size is valued at US$ million in 2021, while the North America and Europe Neurogenetic Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Neurogenetic Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neurogenetic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neurogenetic Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neurogenetic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neurogenetic Testing market.
Global Neurogenetic Testing Scope and Market Size
Neurogenetic Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Neurogenetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
MRI
Next Generation Sequencing
Multiplex Ligation-dependent Probe Amplification (MLPA)
Fragment Analysis PCR
Segment by Application
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
By Company
Labcorp
Pacific Biosciences of California
Victorian Clinical Genetics Services
MedGenome Labs
Blueprint Genetics
GeneDx
Mayo Clinic
Neurogene
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurogenetic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 MRI
1.2.3 Next Generation Sequencing
1.2.4 Multiplex Ligation-dependent Probe Amplification (MLPA)
1.2.5 Fragment Analysis PCR
1.3 Market by Application
1.3.1 Global Neurogenetic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Research Institutes
1.3.5 Diagnostics Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neurogenetic Testing Market Perspective (2017-2028)
2.2 Neurogenetic Testing Growth Trends by Region
2.2.1 Neurogenetic Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neurogenetic Testing Historic Market Size by Region (2017-2022)
2.2.3 Neurogenetic Testing Forecasted Market Size by Region (2023-2028)
2.3 Neurogenetic Testing Market Dynamics
2.3.1 Neurogenetic Testing Industry Trends
2.3.2 Neurogenetic Testing Market Drivers
2.3.3 Neurogenetic Testing Market Challenges
2.3.4 Neurogenetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurogenetic Testing Players by Revenue
3.1.1 Global Top Neurogenetic Testing Players by Revenue (2017-2022)
3.1.2 Global Neurogenetic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurogenetic Testing Revenue
3.4 Global Neurogenetic Testing Market Concentration Ratio
3.4.1 Global Neurogenetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurogenetic Testing Revenue in 2021
3.5 Neurogenetic Testing Key Players Head office and Area Served
3.6 Key Players Neurogenetic Testing Product Solution and Service
3.7 Date of Enter into Neurogenetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurogenetic Testing Breakdown Data by Type
4.1 Global Neurogenetic Testing Historic Market Size by Type (2017-2022)
4.2 Global Neurogenetic Testing Forecasted Market Size by Type (2023-2028)
5 Neurogenetic Testing Breakdown Data by Application
5.1 Global Neurogenetic Testing Historic Market Size by Application (2017-2022)
5.2 Global Neurogenetic Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neurogenetic Testing Market Size (2017-2028)
6.2 North America Neurogenetic Testing Market Size by Type
6.2.1 North America Neurogenetic Testing Market Size by Type (2017-2022)
6.2.2 North America Neurogenetic Testing Market Size by Type (2023-2028)
6.2.3 North America Neurogenetic Testing Market Share by Type (2017-2028)
6.3 North America Neurogenetic Testing Market Size by Application
6.3.1 North America Neurogenetic Testing Market Size by Application (2017-2022)
6.3.2 North America Neurogenetic Testing Market Size by Application (2023-2028)
6.3.3 North America Neurogenetic Testing Market Share by Application (2017-2028)
6.4 North America Neurogenetic Testing Market Size by Country
6.4.1 North America Neurogenetic Testing Market Size by Country (2017-2022)
6.4.2 North America Neurogenetic Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Neurogenetic Testing Market Size (2017-2028)
7.2 Europe Neurogenetic Testing Market Size by Type
7.2.1 Europe Neurogenetic Testing Market Size by Type (2017-2022)
7.2.2 Europe Neurogenetic Testing Market Size by Type (2023-2028)
7.2.3 Europe Neurogenetic Testing Market Share by Type (2017-2028)
7.3 Europe Neurogenetic Testing Market Size by Application
7.3.1 Europe Neurogenetic Testing Market Size by Application (2017-2022)
7.3.2 Europe Neurogenetic Testing Market Size by Application (2023-2028)
7.3.3 Europe Neurogenetic Testing Market Share by Application (2017-2028)
7.4 Europe Neurogenetic Testing Market Size by Country
7.4.1 Europe Neurogenetic Testing Market Size by Country (2017-2022)
7.4.2 Europe Neurogenetic Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurogenetic Testing Market Size (2017-2028)
8.2 Asia-Pacific Neurogenetic Testing Market Size by Type
8.2.1 Asia-Pacific Neurogenetic Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neurogenetic Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neurogenetic Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Neurogenetic Testing Market Size by Application
8.3.1 Asia-Pacific Neurogenetic Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neurogenetic Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neurogenetic Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Neurogenetic Testing Market Size by Region
8.4.1 Asia-Pacific Neurogenetic Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neurogenetic Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neurogenetic Testing Market Size (2017-2028)
9.2 Latin America Neurogenetic Testing Market Size by Type
9.2.1 Latin America Neurogenetic Testing Market Size by Type (2017-2022)
9.2.2 Latin America Neurogenetic Testing Market Size by Type (2023-2028)
9.2.3 Latin America Neurogenetic Testing Market Share by Type (2017-2028)
9.3 Latin America Neurogenetic Testing Market Size by Application
9.3.1 Latin America Neurogenetic Testing Market Size by Application (2017-2022)
9.3.2 Latin America Neurogenetic Testing Market Size by Application (2023-2028)
9.3.3 Latin America Neurogenetic Testing Market Share by Application (2017-2028)
9.4 Latin America Neurogenetic Testing Market Size by Country
9.4.1 Latin America Neurogenetic Testing Market Size by Country (2017-2022)
9.4.2 Latin America Neurogenetic Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurogenetic Testing Market Size (2017-2028)
10.2 Middle East & Africa Neurogenetic Testing Market Size by Type
10.2.1 Middle East & Africa Neurogenetic Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neurogenetic Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neurogenetic Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Neurogenetic Testing Market Size by Application
10.3.1 Middle East & Africa Neurogenetic Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neurogenetic Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neurogenetic Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Neurogenetic Testing Market Size by Country
10.4.1 Middle East & Africa Neurogenetic Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neurogenetic Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Details
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Neurogenetic Testing Introduction
11.1.4 Labcorp Revenue in Neurogenetic Testing Business (2017-2022)
11.1.5 Labcorp Recent Developments
11.2 Pacific Biosciences of California
11.2.1 Pacific Biosciences of California Company Details
11.2.2 Pacific Biosciences of California Business Overview
11.2.3 Pacific Biosciences of California Neurogenetic Testing Introduction
11.2.4 Pacific Biosciences of California Revenue in Neurogenetic Testing Business (2017-2022)
11.2.5 Pacific Biosciences of California Recent Developments
11.3 Victorian Clinical Genetics Services
11.3.1 Victorian Clinical Genetics Services Company Details
11.3.2 Victorian Clinical Genetics Services Business Overview
11.3.3 Victorian Clinical Genetics Services Neurogenetic Testing Introduction
11.3.4 Victorian Clinical Genetics Services Revenue in Neurogenetic Testing Business (2017-2022)
11.3.5 Victorian Clinical Genetics Services Recent Developments
11.4 MedGenome Labs
11.4.1 MedGenome Labs Company Details
11.4.2 MedGenome Labs Business Overview
11.4.3 MedGenome Labs Neurogenetic Testing Introduction
11.4.4 MedGenome Labs Revenue in Neurogenetic Testing Business (2017-2022)
11.4.5 MedGenome Labs Recent Developments
11.5 Blueprint Genetics
11.5.1 Blueprint Genetics Company Details
11.5.2 Blueprint Genetics Business Overview
11.5.3 Blueprint Genetics Neurogenetic Testing Introduction
11.5.4 Blueprint Genetics Revenue in Neurogenetic Testing Business (2017-2022)
11.5.5 Blueprint Genetics Recent Developments
11.6 GeneDx
11.6.1 GeneDx Company Details
11.6.2 GeneDx Business Overview
11.6.3 GeneDx Neurogenetic Testing Introduction
11.6.4 GeneDx Revenue in Neurogenetic Testing Business (2017-2022)
11.6.5 GeneDx Recent Developments
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Details
11.7.2 Mayo Clinic Business Overview
11.7.3 Mayo Clinic Neurogenetic Testing Introduction
11.7.4 Mayo Clinic Revenue in Neurogenetic Testing Business (2017-2022)
11.7.5 Mayo Clinic Recent Developments
11.8 Neurogene
11.8.1 Neurogene Company Details
11.8.2 Neurogene Business Overview
11.8.3 Neurogene Neurogenetic Testing Introduction
11.8.4 Neurogene Revenue in Neurogenetic Testing Business (2017-2022)
11.8.5 Neurogene Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Neurogenetic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of MRI
Table 3. Key Players of Next Generation Sequencing
Table 4. Key Players of Multiplex Ligation-dependent Probe Amplification (MLPA)
Table 5. Key Players of Fragment Analysis PCR
Table 6. Global Neurogenetic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Neurogenetic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Neurogenetic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Neurogenetic Testing Market Share by Region (2017-2022)
Table 10. Global Neurogenetic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Neurogenetic Testing Market Share by Region (2023-2028)
Table 12. Neurogenetic Testing Market Trends
Table 13. Neurogenetic Testing Market Drivers
Table 14. Neurogenetic Testing Market Challenges
Table 15. Neurogenetic Testing Market Restraints
Table 16. Global Neurogenetic Testing Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Neurogenetic Testing Revenue Share by Players (2017-2022)
Table 18. Global Top Neurogenetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenetic Testing as of 2021)
Table 19. Ranking of Global Top Neurogenetic Testing Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Neurogenetic Testing Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Neurogenetic Testing Product Solution and Service
Table 23. Date of Enter into Neurogenetic Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neurogenetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Neurogenetic Testing Revenue Market Share by Type (2017-2022)
Table 27. Global Neurogenetic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Neurogenetic Testing Revenue Market Share by Type (2023-2028)
Table 29. Global Neurogenetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Neurogenetic Testing Revenue Share by Application (2017-2022)
Table 31. Global Neurogenetic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Neurogenetic Testing Revenue Share by Application (2023-2028)
Table 33. North America Neurogenetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Neurogenetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Neurogenetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Neurogenetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Neurogenetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Neurogenetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Neurogenetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Neurogenetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Neurogenetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Neurogenetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Neurogenetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Neurogenetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Neurogenetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Neurogenetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Neurogenetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Neurogenetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Neurogenetic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Neurogenetic Testing Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Neurogenetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Neurogenetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Neurogenetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Neurogenetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Neurogenetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Neurogenetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Neurogenetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Neurogenetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Neurogenetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Neurogenetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Neurogenetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Neurogenetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 63. Labcorp Company Details
Table 64. Labcorp Business Overview
Table 65. Labcorp Neurogenetic Testing Product
Table 66. Labcorp Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 67. Labcorp Recent Developments
Table 68. Pacific Biosciences of California Company Details
Table 69. Pacific Biosciences of California Business Overview
Table 70. Pacific Biosciences of California Neurogenetic Testing Product
Table 71. Pacific Biosciences of California Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 72. Pacific Biosciences of California Recent Developments
Table 73. Victorian Clinical Genetics Services Company Details
Table 74. Victorian Clinical Genetics Services Business Overview
Table 75. Victorian Clinical Genetics Services Neurogenetic Testing Product
Table 76. Victorian Clinical Genetics Services Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 77. Victorian Clinical Genetics Services Recent Developments
Table 78. MedGenome Labs Company Details
Table 79. MedGenome Labs Business Overview
Table 80. MedGenome Labs Neurogenetic Testing Product
Table 81. MedGenome Labs Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 82. MedGenome Labs Recent Developments
Table 83. Blueprint Genetics Company Details
Table 84. Blueprint Genetics Business Overview
Table 85. Blueprint Genetics Neurogenetic Testing Product
Table 86. Blueprint Genetics Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 87. Blueprint Genetics Recent Developments
Table 88. GeneDx Company Details
Table 89. GeneDx Business Overview
Table 90. GeneDx Neurogenetic Testing Product
Table 91. GeneDx Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 92. GeneDx Recent Developments
Table 93. Mayo Clinic Company Details
Table 94. Mayo Clinic Business Overview
Table 95. Mayo Clinic Neurogenetic Testing Product
Table 96. Mayo Clinic Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 97. Mayo Clinic Recent Developments
Table 98. Neurogene Company Details
Table 99. Neurogene Business Overview
Table 100. Neurogene Neurogenetic Testing Product
Table 101. Neurogene Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 102. Neurogene Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurogenetic Testing Market Share by Type: 2021 VS 2028
Figure 2. MRI Features
Figure 3. Next Generation Sequencing Features
Figure 4. Multiplex Ligation-dependent Probe Amplification (MLPA) Features
Figure 5. Fragment Analysis PCR Features
Figure 6. Global Neurogenetic Testing Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Diagnostics Laboratories Case Studies
Figure 11. Neurogenetic Testing Report Years Considered
Figure 12. Global Neurogenetic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Neurogenetic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Neurogenetic Testing Market Share by Region: 2021 VS 2028
Figure 15. Global Neurogenetic Testing Market Share by Players in 2021
Figure 16. Global Top Neurogenetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenetic Testing as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Neurogenetic Testing Revenue in 2021
Figure 18. North America Neurogenetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Neurogenetic Testing Market Size Market Share by Type (2017-2028)
Figure 20. North America Neurogenetic Testing Market Size Market Share by Application (2017-2028)
Figure 21. North America Neurogenetic Testing Market Size Share by Country (2017-2028)
Figure 22. United States Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Neurogenetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Neurogenetic Testing Market Size Market Share by Type (2017-2028)
Figure 26. Europe Neurogenetic Testing Market Size Market Share by Application (2017-2028)
Figure 27. Europe Neurogenetic Testing Market Size Share by Country (2017-2028)
Figure 28. Germany Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Neurogenetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Neurogenetic Testing Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Neurogenetic Testing Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Neurogenetic Testing Market Size Share by Region (2017-2028)
Figure 38. China Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Neurogenetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Neurogenetic Testing Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Neurogenetic Testing Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Neurogenetic Testing Market Size Share by Country (2017-2028)
Figure 48. Mexico Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Neurogenetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Neurogenetic Testing Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Neurogenetic Testing Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Neurogenetic Testing Market Size Share by Country (2017-2028)
Figure 54. Turkey Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Labcorp Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 58. Pacific Biosciences of California Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 59. Victorian Clinical Genetics Services Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 60. MedGenome Labs Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 61. Blueprint Genetics Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 62. GeneDx Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 63. Mayo Clinic Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 64. Neurogene Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


★調査レポート[神経遺伝検査の世界市場インサイト・予測（～2028年）] (コード：QY22JLX09260)販売に関する免責事項を必ずご確認ください。
★調査レポート[神経遺伝検査の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • ラボ用開発テストの世界市場インサイト・予測（～2028年）
  • 子癇前症臨床検査の世界市場インサイト・予測（～2028年）
  • 糖尿病検査プログラムの世界市場インサイト・予測（～2028年）
  • がん向けバイオマーカー検査の世界市場インサイト・予測（～2028年）
  • 院内感染検査の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆